Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Carisma Therapeutics Inc (CARM)

Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Carisma Therapeutics Inc 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 USA

https://carismatx.com P: 267-491-6422

Description:

Carisma Therapeutics Inc. is a late-stage clinical company which focused on advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's advanced product candidate includes Vicineum(TM). Carisma Therapeutics Inc., formerly known as Sesen Bio Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 59,822
Enterprise Value, $K -17,788
Shares Outstanding, K 41,543
Annual Sales, $ 14,920 K
Annual Net Income, $ -86,880 K
Last Quarter Sales, $ 3,400 K
Last Quarter Net Income, $ -18,980 K
EBIT, $ -85,270 K
EBITDA, $ -81,150 K
60-Month Beta 1.51
% of Insider Shareholders 17.00%
% of Institutional Shareholders 44.27%
Float, K 34,481
% Float 83.00%
Short Volume Ratio 0.45

Growth:

1-Year Return -83.45%
3-Year Return -98.23%
5-Year Return -94.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 76.45%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.46 on 05/09/24
Next Earnings Date 08/08/24
Earnings Per Share ttm -2.00
EPS Growth vs. Prev Qtr 11.54%
EPS Growth vs. Prev Year 76.17%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 03/08/23

CARM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -215.95%
Return-on-Assets % -80.58%
Profit Margin % -582.31%
Debt/Equity 0.00
Price/Sales 4.23
Price/Cash Flow N/A
Price/Book 5.80
Book Value/Share 0.26
Interest Coverage -1.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar